Contact Locations Call

Treatment Guide

Component-Resolved Diagnostics (CRD)

Component-resolved diagnostics measure IgE to selected individual allergen proteins rather than only a whole extract. They can refine specific questions about cross-reactivity or reaction probability but are not a universal screening panel.

Patient smiling outdoors after receiving treatment guidance.

Understanding Component-Resolved Diagnostics (CRD)

Component-Resolved Diagnostics (CRD): what the first evaluation should clarify

What component testing can add

For selected foods or pollens, components may help distinguish primary sensitization from cross-reactivity and support a decision about avoidance, challenge, or treatment. The usefulness depends on the allergen and clinical question.

What the result cannot predict

A component result does not diagnose allergy without a compatible history and cannot reliably predict the exact severity of a future reaction. Larger panels can still identify irrelevant sensitization.

Modena Health physician speaking with a patient in an exam room.

Care Options

How the test fits the pathway

The clinician first reviews the event, prior skin or blood testing, tolerated exposures, and the decision that remains. A blood sample is then selected only if the additional component information is likely to change care.

Component-Resolved Diagnostics (CRD) planning questions

Build the component-resolved diagnostics (crd) next step from evidence

Whole-allergen and component tests answer different questions

A whole-allergen test measures IgE binding to a mixture of proteins from the source. Component testing measures selected individual proteins and may help distinguish a stable storage protein from a cross-reactive pollen-related protein in specific clinical situations.

Not every allergen has clinically useful components, and the available panel may not include the protein responsible for a patient’s reaction.

Results do not predict an exact reaction

A component result changes probability; it does not guarantee tolerance, predict the dose that will trigger symptoms, or determine the exact severity of a future reaction. Values from different laboratories, assays, ages, and populations cannot be treated as universal pass-fail cutoffs.

The result must be interpreted with the food or venom history, exposure amount, later tolerance, other test results, and the decision the patient is trying to make.

Know the Next Step

When component testing may change management

Useful questions may include whether a positive peanut or tree-nut test could reflect pollen cross-reactivity, which venom sensitization pattern best matches a sting history, or whether additional evidence would inform a supervised challenge discussion. It should not be used as a broad screening panel in someone who eats the foods without symptoms.

Ask the ordering clinician what each selected component could change before the blood is drawn and how the result will be communicated.

Ask a Molecular-Level Question

Use molecular allergen results to answer one clinical decision

Whole-allergen tests and component-resolved diagnostics do not compete for the title of “most accurate.” They measure different levels of sensitization. A whole extract can show that IgE recognizes material from a food or pollen source; a component test can sometimes identify the particular protein pattern behind that result. The additional detail matters only when it changes counseling, the need for avoidance, or whether a supervised challenge is reasonable.

The most useful order is history first, existing results second, and the unresolved decision third. For example, the clinician may be separating primary food sensitization from pollen-related cross-reactivity, assessing whether two related foods should be discussed separately, or deciding whether more information would improve an oral food challenge risk assessment. Ordering every available component creates more results but not necessarily more clarity.

A component value still cannot predict the exact symptoms or severity of a future reaction. It must be reconciled with foods currently eaten, the form and amount involved in prior reactions, cofactors, and test trends. Review the difference between sensitization and clinical allergy in the allergy blood testing guide before using a molecular result to remove a tolerated food.

Questions About Component-Resolved Diagnostics (CRD)

Frequently Asked Questions About Component-Resolved Diagnostics (CRD)

How is component testing different from a standard allergy blood test?

A standard test may measure IgE to a whole allergen extract, while a component test measures IgE to selected individual proteins within that source. The added detail can refine certain questions, but it does not replace the reaction and exposure history.

Does a positive component result prove that I have an allergy?

No. It shows sensitization to that protein. Clinical allergy requires a compatible history or, when appropriate, clarification through a supervised diagnostic pathway. People may have detectable IgE while tolerating the food or exposure.

Can component testing predict how severe a reaction will be?

No component value can reliably forecast the exact severity of a future reaction. Some patterns change probability estimates in defined situations, but individual reactions also depend on dose, cofactors, asthma control, and other variables.

When is component-resolved diagnostics most useful?

It is most useful when the clinician can name the decision the result may change, such as evaluating cross-reactivity, refining selected food-allergy counseling, or planning whether an oral food challenge deserves consideration.

Care Connected with Component-Resolved Diagnostics (CRD)

Evaluation and treatment related to Component-Resolved Diagnostics (CRD)

These diagnostic and treatment topics can shape a focused component-resolved diagnostics (crd) discussion.

Allergy Blood Testing and Specific IgE Results

Allergy Blood Testing and Specific IgE Results can clarify a separate question that often appears while evaluating Component-Resolved Diagnostics (CRD).

View guide

Food Allergy Testing and Evaluation

Use the Food Allergy Testing and Evaluation guide to compare preparation, evidence, and next steps alongside Component-Resolved Diagnostics (CRD).

View guide

Oral Food Challenges

Open Oral Food Challenges for connected testing or treatment decisions that may follow a Component-Resolved Diagnostics (CRD) discussion.

View guide

Plan the next component-resolved diagnostics (crd) conversation

Bring the symptom, reaction, testing, and treatment records named in this Component-Resolved Diagnostics (CRD) guide so the visit can answer a focused question.